Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-29 @ 4:37 PM
Study NCT ID:
NCT00079768
Status:
COMPLETED
Last Update Posted:
2010-06-17
First Post:
2004-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-03-12
First Submit QC Date:
None
Study First Post Date:
2004-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-06-16
Last Update Post Date:
2010-06-17
Last Update Post Date Type:
ESTIMATED